C12N 2710/14141
Use of virus, viral particle or viral elements as a vector
C12N2710/14141 (Use of virus, viral particle or viral elements as a vector) appears on 519 US grants and 524 published applications in this corpus.
Search patents in C12N- Granted patents
- 519
- Published applications
- 524
- Assignees
- 357
- Inventors
- 1,241
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 6 | 0 |
| 1992 | 10 | 0 |
| 1993 | 12 | 0 |
| 1994 | 13 | 0 |
| 1995 | 8 | 0 |
| 1996 | 10 | 0 |
| 1997 | 23 | 0 |
| 1998 | 27 | 0 |
| 1999 | 29 | 0 |
| 2000 | 17 | 0 |
| 2001 | 31 | 1 |
| 2002 | 20 | 21 |
| 2003 | 9 | 15 |
| 2004 | 18 | 35 |
| 2005 | 11 | 29 |
| 2006 | 16 | 21 |
| 2007 | 16 | 19 |
| 2008 | 19 | 26 |
| 2009 | 8 | 32 |
| 2010 | 14 | 33 |
| 2011 | 15 | 25 |
| 2012 | 9 | 21 |
| 2013 | 13 | 23 |
| 2014 | 17 | 10 |
| 2015 | 17 | 21 |
| 2016 | 13 | 12 |
| 2017 | 15 | 11 |
| 2018 | 15 | 17 |
| 2019 | 15 | 19 |
| 2020 | 16 | 22 |
| 2021 | 6 | 21 |
| 2022 | 13 | 21 |
| 2023 | 9 | 20 |
| 2024 | 5 | 26 |
| 2025 | 14 | 11 |
| 2026 | 6 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2710/14143Viral genome or elements thereof as genetic vectorIndexing code505
- C12N 2710/14144Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code31
- C12N 2710/14145Special targeting system for viral vectorsIndexing code6
- C12N 2710/14142Virus or viral particle as vehicleIndexing code1
Recent patents
- Baculovirus expression system28 Jul 2026US 12,692,481 B2Virovek, Inc.
- SmartBac baculovirus expression system and application thereof9 Jun 2026US 12,649,931 B2Institute of Biophysics, Chinese Pie Academy of Sciences
- Therapeutic viral microparticles for promoting stent biofunctionality and wound healing in vertebrate individuals2 Jun 2026US 12,642,831 B2MangoGen Pharma, Inc.
- AAV6 variants12 May 2026US 12,624,367 B2University of Florida Research Foundation, Inc.
- Baculovirus vector and use thereof in preparation of recombinant adeno-associated virus (rAAV) in insect cell10 Mar 2026US 12,571,001 B2Genevoyager (Wuhan) Co., Ltd.
- A Fusion Protein and a Particulate Antigen Containing the Same27 Aug 2026US 2026/0250328 A1Xiamen Innovax Biotech Co., Ltd.
- Fusion protein of ge and gi of varicella-zoster virus and use6 Aug 2026US 2026/0224694 A1
- Modified g protein coupled receptor and use thereof23 Jul 2026US 2026/0209311 A1Alphelix Biotech Co., Ltd.
- Methods and compositions for enriching circulating cell-free nucleic acids in a biological sample25 Jun 2026US 2026/0176705 A1Centre for Novostics
- Virus-like nanocapsid for oral delivery of insulin11 Jun 2026US 2026/0159817 A1The Regents of the University of California
Most cited
By later US patents
- Insect control agent288US 6,326,193 B1Cambria Biosciences, LLC · 2001
- Method for producing a recombinant baculovirus expression vector209US 4,745,051 AThe Texas A&M University System · 1988
- Baculovirus expression system and method for high throughput expression of genetic material170US 6,225,060 B1Onyx Pharmaceuticals, Inc. · 2001
- Method for producing a recombinant baculovirus expression vector164US 4,879,236 AThe Texas A&M University System · 1989
- Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein146US 5,858,368 AProtein Sciences Corporation · 1999